Anita K. Bakrania - Publications

Corrigendum to "Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice" [Regulat. Toxicol. Pharmacol. RTP 101 (2019) 71-78].

Journal: Regulatory toxicology and pharmacology : RTP

Published: August 03, 2025

Corrigendum to "Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety" Biomed. Pharmacother. 108 (2018) 1274-1281.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 19, 2024

Corrigendum: Role of β-interferon inducer (DEAE-Dextran) in tumorigenesis by VEGF and NOTCH1 inhibition along with apoptosis induction.

Journal: Frontiers in pharmacology

Published: May 16, 2024

Corrigendum to "DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition" [Eur. J. Pharm. Biopharm. 122 (2018) 37-48].

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: December 23, 2023

Retraction Note to: Insights from diversified anti-angiogenic models: role of β-interferon inducer DEAE-Dextran.

Journal: Pharmacological reports : PR

Published: July 05, 2022

Ameliorative Effect of a Neoteric Regimen of Catechin plus Cetirizine on Ovalbumin-Induced Allergic Rhinitis in Rats.

Journal: Life (Basel, Switzerland)

Published: April 22, 2022

Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: January 22, 2019

Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 09, 2018

Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice.

Journal: Regulatory toxicology and pharmacology : RTP

Published: April 12, 2018

Insights from diversified anti-angiogenic models: Role of β-interferon inducer DEAE-Dextran.

Journal: Pharmacological reports : PR

Published: July 18, 2017

DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: March 28, 2017

Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.

Journal: Frontiers in pharmacology

Published: March 23, 2017